vs
GoodRx Holdings, Inc.（GDRX）与Rocket Lab Corp（RKLB）财务数据对比。点击上方公司名可切换其他公司
GoodRx Holdings, Inc.的季度营收约是Rocket Lab Corp的1.1倍（$194.8M vs $179.7M），GoodRx Holdings, Inc.净利率更高（2.8% vs -29.5%，领先32.2%），Rocket Lab Corp同比增速更快（35.7% vs -1.9%），GoodRx Holdings, Inc.自由现金流更多（$31.6M vs $-114.2M），过去两年Rocket Lab Corp的营收复合增速更高（39.2% vs -0.8%）
GoodRx是一家美国医疗健康企业，运营着远程医疗平台以及可免费使用的网站与移动应用，服务覆盖美国超75000家药店，可为用户追踪处方药价格、提供药品优惠折扣券，还支持用户在线问诊，获取部分品类药物的处方。
Rocket Lab是公开上市的航空航天制造商及发射服务提供商，旗下Electron轨道火箭主打小型卫星发射，截至2026年1月已成功完成超75次任务，是全球现役发射次数最多的小型运载火箭。公司还开发了Electron的亚轨道改型HASTE用作高超音速技术测试平台，下一代可复用中型运载火箭Neutron目前也在研发中。
GDRX vs RKLB — 直观对比
营收规模更大
GDRX
是对方的1.1倍
$179.7M
营收增速更快
RKLB
高出37.6%
-1.9%
净利率更高
GDRX
高出32.2%
-29.5%
自由现金流更多
GDRX
多$145.8M
$-114.2M
两年增速更快
RKLB
近两年复合增速
-0.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $194.8M | $179.7M |
| 净利润 | $5.4M | $-52.9M |
| 毛利率 | — | 38.0% |
| 营业利润率 | 11.6% | -28.4% |
| 净利率 | 2.8% | -29.5% |
| 营收同比 | -1.9% | 35.7% |
| 净利润同比 | -19.5% | -1.1% |
| 每股收益（稀释后） | $0.02 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GDRXRKLB
| Q4 25 | $194.8M | $179.7M | ||
| Q3 25 | $196.0M | $155.1M | ||
| Q2 25 | $203.1M | $144.5M | ||
| Q1 25 | $203.0M | $122.6M | ||
| Q4 24 | $198.6M | $132.4M | ||
| Q3 24 | $195.3M | $104.8M | ||
| Q2 24 | $200.6M | $106.3M | ||
| Q1 24 | $197.9M | $92.8M |
净利润GDRXRKLB
| Q4 25 | $5.4M | $-52.9M | ||
| Q3 25 | $1.1M | $-18.3M | ||
| Q2 25 | $12.8M | $-66.4M | ||
| Q1 25 | $11.1M | $-60.6M | ||
| Q4 24 | $6.7M | $-52.3M | ||
| Q3 24 | $4.0M | $-51.9M | ||
| Q2 24 | $6.7M | $-41.6M | ||
| Q1 24 | $-1.0M | $-44.3M |
毛利率GDRXRKLB
| Q4 25 | — | 38.0% | ||
| Q3 25 | — | 37.0% | ||
| Q2 25 | — | 32.1% | ||
| Q1 25 | — | 28.8% | ||
| Q4 24 | — | 27.8% | ||
| Q3 24 | — | 26.7% | ||
| Q2 24 | — | 25.6% | ||
| Q1 24 | — | 26.1% |
营业利润率GDRXRKLB
| Q4 25 | 11.6% | -28.4% | ||
| Q3 25 | 7.5% | -38.0% | ||
| Q2 25 | 13.2% | -41.3% | ||
| Q1 25 | 11.5% | -48.3% | ||
| Q4 24 | 9.2% | -38.9% | ||
| Q3 24 | 10.5% | -49.5% | ||
| Q2 24 | 9.9% | -40.7% | ||
| Q1 24 | 3.7% | -46.4% |
净利率GDRXRKLB
| Q4 25 | 2.8% | -29.5% | ||
| Q3 25 | 0.6% | -11.8% | ||
| Q2 25 | 6.3% | -46.0% | ||
| Q1 25 | 5.4% | -49.5% | ||
| Q4 24 | 3.4% | -39.5% | ||
| Q3 24 | 2.0% | -49.6% | ||
| Q2 24 | 3.3% | -39.2% | ||
| Q1 24 | -0.5% | -47.7% |
每股收益（稀释后）GDRXRKLB
| Q4 25 | $0.02 | $-0.09 | ||
| Q3 25 | $0.00 | $-0.03 | ||
| Q2 25 | $0.04 | $-0.13 | ||
| Q1 25 | $0.03 | $-0.12 | ||
| Q4 24 | $0.01 | $-0.11 | ||
| Q3 24 | $0.01 | $-0.10 | ||
| Q2 24 | $0.02 | $-0.08 | ||
| Q1 24 | $0.00 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $261.8M | $1.0B |
| 总债务越低越好 | $495.0M | $152.4M |
| 股东权益账面价值 | $616.3M | $1.7B |
| 总资产 | $1.4B | $2.3B |
| 负债/权益比越低杠杆越低 | 0.80× | 0.09× |
8季度趋势，按日历期对齐
现金及短期投资GDRXRKLB
| Q4 25 | $261.8M | $1.0B | ||
| Q3 25 | $273.5M | $976.7M | ||
| Q2 25 | $281.3M | $688.1M | ||
| Q1 25 | $301.0M | $428.4M | ||
| Q4 24 | $448.3M | $419.0M | ||
| Q3 24 | $423.8M | $442.4M | ||
| Q2 24 | $524.9M | $496.8M | ||
| Q1 24 | $533.3M | $492.5M |
总债务GDRXRKLB
| Q4 25 | $495.0M | $152.4M | ||
| Q3 25 | — | $347.0M | ||
| Q2 25 | — | $346.5M | ||
| Q1 25 | — | $345.9M | ||
| Q4 24 | $500.0M | $345.4M | ||
| Q3 24 | — | $61.2M | ||
| Q2 24 | — | $64.2M | ||
| Q1 24 | — | $66.8M |
股东权益GDRXRKLB
| Q4 25 | $616.3M | $1.7B | ||
| Q3 25 | $600.7M | $1.3B | ||
| Q2 25 | $643.0M | $688.5M | ||
| Q1 25 | $654.3M | $431.3M | ||
| Q4 24 | $724.7M | $382.5M | ||
| Q3 24 | $696.4M | $419.8M | ||
| Q2 24 | $669.4M | $455.2M | ||
| Q1 24 | $631.1M | $478.9M |
总资产GDRXRKLB
| Q4 25 | $1.4B | $2.3B | ||
| Q3 25 | $1.3B | $2.2B | ||
| Q2 25 | $1.3B | $1.6B | ||
| Q1 25 | $1.3B | $1.3B | ||
| Q4 24 | $1.4B | $1.2B | ||
| Q3 24 | $1.4B | $1.2B | ||
| Q2 24 | $1.5B | $1.2B | ||
| Q1 24 | $1.5B | $1.2B |
负债/权益比GDRXRKLB
| Q4 25 | 0.80× | 0.09× | ||
| Q3 25 | — | 0.27× | ||
| Q2 25 | — | 0.50× | ||
| Q1 25 | — | 0.80× | ||
| Q4 24 | 0.69× | 0.90× | ||
| Q3 24 | — | 0.15× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | — | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $32.9M | $-64.5M |
| 自由现金流经营现金流 - 资本支出 | $31.6M | $-114.2M |
| 自由现金流率自由现金流/营收 | 16.2% | -63.6% |
| 资本支出强度资本支出/营收 | 0.6% | 27.6% |
| 现金转化率经营现金流/净利润 | 6.06× | — |
| 过去12个月自由现金流最近4个季度 | $164.4M | $-321.8M |
8季度趋势，按日历期对齐
经营现金流GDRXRKLB
| Q4 25 | $32.9M | $-64.5M | ||
| Q3 25 | $76.0M | $-23.5M | ||
| Q2 25 | $49.6M | $-23.2M | ||
| Q1 25 | $9.4M | $-54.2M | ||
| Q4 24 | $44.7M | $-2.4M | ||
| Q3 24 | $86.9M | $-30.9M | ||
| Q2 24 | $9.7M | $-13.0M | ||
| Q1 24 | $42.6M | $-2.6M |
自由现金流GDRXRKLB
| Q4 25 | $31.6M | $-114.2M | ||
| Q3 25 | $74.3M | $-69.4M | ||
| Q2 25 | $49.2M | $-55.3M | ||
| Q1 25 | $9.3M | $-82.9M | ||
| Q4 24 | $44.6M | $-23.9M | ||
| Q3 24 | $86.5M | $-41.9M | ||
| Q2 24 | $9.4M | $-28.3M | ||
| Q1 24 | $42.2M | $-21.8M |
自由现金流率GDRXRKLB
| Q4 25 | 16.2% | -63.6% | ||
| Q3 25 | 37.9% | -44.8% | ||
| Q2 25 | 24.2% | -38.3% | ||
| Q1 25 | 4.6% | -67.6% | ||
| Q4 24 | 22.4% | -18.1% | ||
| Q3 24 | 44.3% | -40.0% | ||
| Q2 24 | 4.7% | -26.7% | ||
| Q1 24 | 21.3% | -23.5% |
资本支出强度GDRXRKLB
| Q4 25 | 0.6% | 27.6% | ||
| Q3 25 | 0.9% | 29.6% | ||
| Q2 25 | 0.2% | 22.2% | ||
| Q1 25 | 0.1% | 23.4% | ||
| Q4 24 | 0.1% | 16.3% | ||
| Q3 24 | 0.2% | 10.5% | ||
| Q2 24 | 0.1% | 14.4% | ||
| Q1 24 | 0.2% | 20.7% |
现金转化率GDRXRKLB
| Q4 25 | 6.06× | — | ||
| Q3 25 | 67.94× | — | ||
| Q2 25 | 3.86× | — | ||
| Q1 25 | 0.85× | — | ||
| Q4 24 | 6.64× | — | ||
| Q3 24 | 21.91× | — | ||
| Q2 24 | 1.45× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GDRX
| Prescription Transactions Revenue | $124.7M | 64% |
| Other | $44.4M | 23% |
| Subscription Revenue | $21.6M | 11% |
| Other Revenue | $4.1M | 2% |
RKLB
| Products | $94.0M | 52% |
| Transferred Over Time | $87.3M | 49% |
